The Virtual CVOT Summit 2025 will start on 20 November at 15:00 CET.The livestream will start today at 15:00 CET.Thursday, 20 November 2025Welcome and Introduction15:00 – 15:10 CETOliver Schnell (Munich, Germany)New Horizons in Cardiovascular, Kidney and Metabolic Care15:10 – 16:15 CETChairs: Jennifer Green (Durham, NC, USA), John McMurray (Glasgow, UK)On the Evolution of CardioVascular Outcome Trials (CVOTs)15:10 – 15:25Scott Solomon (Boston, MA, USA)SURPASSing Previous Boundaries: Incretine Mimetics and Cardiorenal Outcomes15:25 – 15:45Stefano del Prato (Pisa, Italy)The Aldosterone Pathway Revisited: Novel Approaches in Hypertension Management15:45 – 16:00Michel Azizi (Paris, France)Discussion16:00 – 16:15From Study to Guideline to Practice: Making Clinical Evidence Work16:15 – 17:30 CETChairs: Helena Rodbard (Rockville, MD, USA), Frank Tacke (Berlin, Germany)Perspectives of the Guideline Workshop (1) Obesity: New Opportunities for Network Meta-Analyses16:15 – 16:30Arnav Agarwal (Hamilton, Canada)Perspectives of the Guideline Workshop (2) Implementation of Guidelines at National Level: Perspectives of the European Renal Association (ERA)16:30 – 16:45Christoph Wanner (Wuerzburg, Germany)Breaking Barriers in Hard to Control Hypertension: Key Insights for Practitioners16:45 – 17:00Kamlesh Khunti (Leicester, UK)Putting Person-Centered Care into Practice: What Matters to Patients with Chronic Liver Disease17:00 – 17:15Marko Korenjak (Brussels, Belgium)Discussion17:15 – 17:30Break17:30 – 17:45Policy Session: Transforming Cardiometabolic Health: Advancing Science, Integrated Care and Policy17:45 – 18:30 CETChair: Oliver Schnell (Munich, Germany)EU Policies to Improve Cardiovascular Health17:45 – 17:55MEP Romana Jerković (Brussels, Belgium)Towards an Inclusive EU CV Plan17:55 – 18:05Chantal Mathieu (Leuven, Belgium)Cardiovascular Health: How to Transition to National Progress18:05 – 18:15Dirk Müller-Wieland (Aachen, Germany)Hellmut Mehnert Award18:30 – 19:30 CETChairs: Rury Holman (Oxford UK), Eberhard Standl (Munich, Germany)Introduction of the Award18:30 – 18:40Eberhard Standl (Munich, Germany)Laudation and Presentation of Awardee18:40 – 18:45Rury Holman (Oxford, UK)The Discovery of Multi-Receptor Drugs: The end of obesity and type 2 diabetes?18:45 – 19:25Matthias Tschöp (Munich, Germany)Closing19:25 – 19:30Rury Holman (Oxford UK), Eberhard Standl (Munich, Germany)Oral Presentations – Part 119:30 – 20:15 CETChairs: Dipesh Patel (London, UK), Nikolaos Papanas (Alexandroupolis, Greece)OP 1: Prediabetes Remission and Long-Term Risk of Cardiovascular Death, Heart Failure Hospitalization, and All-Cause Mortality19:30 – 20:15Andreas Birkenfeld (Tuebingen, Germany)OP 2: Clinical association of diabetes mellitus and heart failure with metabolic dysfunction-associated steatotic liver diseaseKateryna Pivtorak (Vinnytsia, Ukraine)OP 3: Relationship between undiagnosed diabetes, cardiovascular events and mortality in acute coronary syndrome patients enrolled in the STRONG-MI registryFaisal Aziz (Graz, Austria)OP 4: Influence of Diabetes Mellitus on Thrombosis in Branch Retinal Vein OcclusionMarianne Shahsuvaryan (Yerevan, Armenia)Closing of Day 120:15 CETOliver Schnell (Munich, Germany)The livestream will start today at 08:45 CET.Friday, 21 November 2025Advancing Early Detection and Preventive Strategies in Type 1 Diabetes08:45 – 09:30Chair: Thomas Danne (Lisbon, Portugal)C-Peptide as a Surrogate Parameter for Residual Beta Cell Function in Type 1 Diabetes and its Potential Clinical Role08:45 – 09:00Colin M. Dayan (Cardiff, UK)Targeting Autoimmunity in Type 1 Diabetes: Emerging Disease-Modifying Strategies09:00 – 09:15Chantal Mathieu (Leuven, Belgium)Discussion09:15 – 09:30Continuous Monitoring: Current and Emerging Perspectives09:30 – 10:45 CETChair: Julia Mader (Graz, Austria)The Heartbeat of Glucose: CGM’s Role in Cardiovascular Outcomes in Diabetes09:30 – 09:45 Tadej Battelino (Ljubljana, Slovenia)Building CGM Expertise: Recommendations for Education and Practice09:45 – 10:00Pratik Choudhary (Leicester, UK)Continuous Ketone Monitoring: A New Era in Metabolic Management10:10 – 10:15Susanne Reger-Tan (Bad Oeynhausen, Germany)Discussion10:15 – 10:30 Break10:30 – 10:40 CETSatellite Symposium See Further, Act Smarter: How AI Is Transforming Diabetes Care10:40 – 10:55 CETJohn Pemberton (Birmingham, UK) Supported by Roche Diagnostics International Ltd.Break10:55 – 11:00 CETThe Silent Link: Diabetes and Chronic Kidney Disease11:00 – 12:00 CETChairs: Rury Holman (Oxford, UK), Paola Fioretto (Padua, Italy)Kidney Protection in Type 1 Diabetes: Are Non-Steroidal MRAs the Next Step? 11:00 – 11:15Hiddo Heerspink (Groningen, The Netherlands)SGLT2 Inhibitors and Non-Steroidal MRAs: Combining Forces for Cardiorenal Protection11:15 – 11:30Johannes Mann (Munich, Germany)Future Directions in the Treatment of Chronic Kidney Disease11:30 – 11:45Parminder Judge (Oxford, UK)Discussion11:45 – 12:00Integrated Approaches in Heart Failure Therapy12:00 – 13:00 CETChair: Naoki Sato (Kawaguchi, Japan), Henrike Arfsten (Vienna, Austria)SGLT2 Inhibitors – Changing the Game in Heart Failure Treatment12:00 – 12:15Nikolaus Marx (Aachen, Germany)Changing Landscape in HFpEF: New Therapeutic Strategies12:15 – 12:30 Pardeep Jhund (Glasgow, UK)Emerging Treatment Strategies in HFrEF12:30 – 12:45Giuseppe Rosano (London, UK)Discussion12:45 – 13:00Break13:00 – 13:30Multidisciplinary Strategies in Obesity and Metabolic Liver Disorders13:30 – 15:00 CETChairs: Matthias Blüher (Leipzig, Germany), Linong Ji (Beijing, China)Obesity 2025 – State of the Art in Diagnosis and Therapy13:30 – 13:45Timothy Garvey (Birmingham, AL, USA)One Target Is Not Enough? Novel GLP-1-Based Treatment Approaches13:45 – 14:00Sean Wharton (Toronto, Canada)Discussion14:00 – 14:15The Liver in Distress: Managing Obesity-Related MASLD14:15 – 14:30Elisabetta Bugianesi (Turin, Italy)Nutrition Under Incretin Therapy14:30 – 14:45Andreas Pfeiffer (Berlin, Germany)Discussion14:45 – 15:00The Global Alliance for Cardio-Kidney-Metabolic Care – Holistic Approaches to Improve Clinical Care15:00 – 15:30 CETChairs: Stephan Jacob (Villingen-Schwenningen, Germany), Andrew Krentz (London, UK)Beyond LDL Lowering: Managing the Residual Risk in ASCVD15:00 – 15:15Peter Libby (Boston, MA, USA)Why Do We Need to Establish Cardio-Metabolic-Renal Care and Beyond?15:15 – 15:30Robert Eckel (Denver, CO, USA)Practical Implementation in Primary Care: A Hands-On Session15:30 – 16:30 CETChairs: Pinar Topsever (Istanbul, Turkey), Baruch Itzhak (Haifa, Israel)Why Early Diagnosis Matters, and How to Put It into Practice in Chronic Kidney Disease15:30 – 15:45Ana Cebrian (Murcia, Spain)Supporting Patient Adherence – Practical Strategies for Clinical Practice15:45 – 16:00Katharine Barnard-Kelly (Hampshire, UK)Translating Guidelines into Practice: A Heart Failure Nurse’s Perspective16:00 – 16:15Ekaterini Lambrinou (Limassol, Cyprus)Discussion16:15 – 16:30Break16:30 – 16:45Industry’s perspective - Panel Discussion16:45 – 17:45 CETOliver Schnell (Munich, Germany)Oral Presentations – Part 217:45 – 18:30 CETChairs: Banshi Saboo (Ahmedabad, India), Antonio Ceriello (Milan, Italy)OP 5: A Time In Range of 70% Attenuates the Senescence-Inducing and Pro-Inflammatory Effects of Hyperglycemia17:45 – 18:30Rosalba La Grotta (Milan, Italy)OP 6: Monitoring ketone levels continuously during a 7-day fastNina Jendrike (Ulm, Germany)OP 7: Routine Biopsychosocial Care Is Practical and AchievableKatharine Barnard-Kelly (Fareham, UK)OP 8: Pharmacist-Led Consultations for Continuous Glucose Monitoring Users: Knowledge, Confidence, and Opportunities to Support Diabetes Management and OutcomesAnastasija Levkina (Vilnius, Lithuania)Abstract Award and Closing18:30 – 18:45 CETOliver Schnell (Munich, Germany) Thank you for your attendance and contribution to the Virtual CVOT Summit 2025. See you next year for the 12th CVOT Summit on 19 - 20 November 2026. We will be right back.We are currently having some technical issues. We will be right back.The page is automatically updated.The next program item is loaded.
Virtual CVOT Summit 2025 11th Annual Congress on Cardiovascular, Kidney and Metabolic Outcome
